Hexagon Capital Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-73
| Closed | -$17.8K | – | 263 |
|
|
2025
Q1 | $17.8K | Buy |
73
+1
| +1% | +$244 | ﹤0.01% | 794 |
|
|
2024
Q4 | $23.7K | Hold |
72
| – | – | ﹤0.01% | 733 |
|
|
2024
Q3 | $24.1K | Hold |
72
| – | – | ﹤0.01% | 647 |
|
|
2024
Q2 | $19.7K | Hold |
72
| – | – | ﹤0.01% | 691 |
|
|
2024
Q1 | $24.9K | Hold |
72
| – | – | 0.01% | 616 |
|
|
2023
Q4 | $23.2K | Hold |
72
| – | – | 0.01% | 587 |
|
|
2023
Q3 | $25.8K | Hold |
72
| – | – | 0.01% | 495 |
|
|
2023
Q2 | $27.3K | Hold |
72
| – | – | 0.01% | 483 |
|
|
2023
Q1 | $34.5K | Hold |
72
| – | – | 0.01% | 426 |
|
|
2022
Q4 | $30.3K | Hold |
72
| – | – | 0.01% | 452 |
|
|
2022
Q3 | $30K | Hold |
72
| – | – | 0.01% | 494 |
|
|
2022
Q2 | $36K | Hold |
72
| – | – | 0.01% | 423 |
|
|
2022
Q1 | $41K | Hold |
72
| – | – | 0.01% | 396 |
|
|
2021
Q4 | $54K | Hold |
72
| – | – | 0.01% | 349 |
|
|
2021
Q3 | $54K | Hold |
72
| – | – | 0.02% | 334 |
|
|
2021
Q2 | $46K | Hold |
72
| – | – | 0.01% | 335 |
|
|
2021
Q1 | $41K | Hold |
72
| – | – | 0.01% | 327 |
|
|
2020
Q4 | $41K | Hold |
72
| – | – | 0.01% | 293 |
|
|
2020
Q3 | $42K | Buy |
+72
| New | +$42K | 0.01% | 273 |
|